Skip to search formSkip to main contentSkip to account menu

BNP-166

Known as: BNP166 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

etiprednol dicloacetate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Anti-inflammatory effect and soft properties of etiprednol dicloacetate (BNP-166), a new, anti-asthmatic steroid.
In vitro and in vivo anti-inflammatory properties and soft characteristics of etiprednol dicloacetate (BNP-166) a new steroid… 
2004
2004
HPLC separation of related impurities in etiprednol dicloacetate, a novel soft corticosteroid.
Etiprednol dicloacetate (ethyl 17alpha-dichloroacetoxy-11beta-hydroxy-androsta-1,4-diene-3-one-17beta-carboxylate, code-named… 
2004
2004
Etiprednol dicloacetate, a new soft glucocorticoid drug candidate. Development of chemistry.
During development of chemistry of the soft drug candidate etiprednol dicloacetate (BNP-166) 1) optimization studies on the three… 
2003
2003
Potency and Specificity of the Pharmacological Action of a New, Antiasthmatic, Topically Administered Soft Steroid, Etiprednol Dicloacetate (BNP-166)
In the present study, the pharmacological effects of etiprednol dicloacetate (BNP-166; ethyl-17α-dichloroacetoxy-11… 
2002
2002
28-day oral toxicity study with soft corticosteroid BNP-166 in rats and dogs, followed by a 14-day recovery period.
The aim of the present study was to evaluate the soft corticosteroid BNP-166 in rats and dogs treated orally with 0.2, 2.0, and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)